Cargando…
Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives
COVID-19 (coronavirus disease 2019), caused by the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), emerged in Wuhan, China, and has spread worldwide, resulting in over 73 million cases and more than 1 600 000 deaths as of December 2020. Although the disease is asympto...
Autores principales: | Memish, Ziad A., Faqihi, Fahad, Alharthy, Abdulrahman, Alqahtani, Saleh A., Karakitsos, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834644/ https://www.ncbi.nlm.nih.gov/pubmed/33370568 http://dx.doi.org/10.1016/j.ijantimicag.2020.106273 |
Ejemplares similares
-
Life-threatening COVID-19 presenting as stroke with antiphospholipid
antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma
exchange: A case series
por: Alharthy, Abdulrahman, et al.
Publicado: (2020) -
Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
por: Faqihi, Fahad, et al.
Publicado: (2020) -
Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome
por: Faqihi, Fahad, et al.
Publicado: (2020) -
Therapeutic plasma exchange in adult critically ill patients
with life-threatening SARS-CoV-2 disease: A pilot study
por: Faqihi, Fahad, et al.
Publicado: (2020) -
Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study
por: Alharthy, Abdulrahman, et al.
Publicado: (2021)